Related Experiment Video

Updated: Dec 14, 2025

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.4K

A consensus guideline of herbal medicine for coronavirus disease 2019

Beom-Joon Lee1, Ju Ah Lee2, Kwan-Il Kim1

  • 1Division of Allergy, Immune and Respiratory System, Department of Internal Medicine, College of Korean Medicine, Kyung Hee University Seoul, Republic of Korea.

Integrative Medicine Research
|July 22, 2020
PubMed

Insights

Korean herbal medicine (HM) offers treatment options for SARS-CoV-2, including prevention, post-exposure, and recovery stages. Specific herbal preparations are recommended based on symptom presentation and disease progression for COVID-19 patients.

Area of Science:

  • Integrative Medicine
  • Pharmacology
  • Infectious Disease Management

Background:

  • Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic originated in late 2019.
  • Analysis of SARS-CoV-2 symptoms and traditional Chinese medicine (TCM) treatment regimens.
  • Recommendation of Korean medicine preparations for domestic medical insurance benefits.

Purpose of the Study:

  • To develop a clinical practice guideline (CPG) for treating SARS-CoV-2 using Korean herbal medicine.
  • To provide evidence-based recommendations for the use of specific herbal preparations.
  • To establish a framework for treating similar infectious diseases.

Main Methods:

  • Development of a CPG based on expert consensus.
  • Classification of herbal medicine (HM) recommendations according to disease stage and symptoms.
  • Integration of traditional Korean medicine principles with modern medical understanding.

Main Results:

  • Prevention: Youngyopaedoc-san plus Bojungikgitang or Saengmaek-san.
  • Post-exposure: Youngyopaedoc-san plus Bulhwangeumjeonggi-san or Bojungikgi-tang.
  • Mildly symptomatic COVID-19: Youngyopaedoc-san plus Galgunhaegui-tang (wind-warmth) or Sosiho-tang plus Bulhwangeumjeonggi-san (dampness-heat).
  • Recovery: Samchulkunbi-tang plus Saengmaek-san or Chungseuiki-tang.

Conclusions:

  • The CPG guides the use of Korean herbal medicine for SARS-CoV-2 treatment.
  • Recommendations are tailored to different stages of the disease and specific symptom patterns.
  • This guideline serves as a foundation for managing future infectious disease outbreaks.
Abstract

Keywords:
Clinical practice guidelineHerbal medicineKorean medicineSARS-CoV-2

More Related Videos

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K
Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension05:19

Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension

Published on: September 1, 2023

1.9K

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
525
Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
642
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
760
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
895